Securidaca longepedunculata (Securidaca longepedunculata): Benefits, Dosage, Safety & Evidence

Questions fréquentes

What are the traditional uses of Securidaca longepedunculata?

Securidaca longepedunculata is a Southern African tree considered sacred in Venda, Zulu, and Ndebele traditions. It is traditionally used for a wide range of conditions, including malaria, sexually transmitted infections, and various skin diseases. Additionally, traditional healers utilize the roots and bark for mental illness and general pain relief. While ethnobotanical use is extensive, scientific support for these specific indications remains limited (Evidence Level C).

How does Securidaca longepedunculata work medicinally?

The plant's medicinal activity is primarily attributed to methylsalicylate, which provides analgesic and anti-inflammatory effects similar to aspirin. It also contains saponins and coumarins, which contribute to its antimicrobial properties useful against infections. Flavonoids and tannins offer additional antioxidant support. These compounds act synergistically, though the specific pharmacokinetic pathways and mechanisms for treating mental illness require further scientific validation.

What is the safe dosage for Securidaca longepedunculata bark?

Due to the plant's narrow therapeutic window, dosage must be strictly controlled. Traditional guidelines suggest adult doses of dried bark should be limited to small amounts, typically 0.5g to 1g. However, because the herb possesses neurotoxic properties and can cause severe side effects in overdose, it should never be self-administered. Professional supervision is strongly recommended to ensure safety (Evidence Level C).

Is Securidaca longepedunculata safe to use during pregnancy?

No, Securidaca longepedunculata is unsafe during pregnancy. The presence of methylsalicylate and other toxic constituents poses significant risks, including potential teratogenic effects and uterine stimulation. Traditional contraindications explicitly warn against use by pregnant women. Furthermore, individuals with liver disease should avoid this herb due to the risk of hepatotoxicity associated with improper dosing or prolonged use.

Does Securidaca longepedunculata interact with other drugs?

Yes, significant drug interactions are possible. Due to the presence of coumarins, there is a theoretical risk of increased bleeding when combined with anticoagulant medications like warfarin. Additionally, the methylsalicylate content may potentiate the effects of other salicylates or NSAIDs. Because the herb is neurotoxic at high doses, it may also interact dangerously with central nervous system depressants or medications metabolized by the liver.

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Securidaca longepedunculata is a medicinal plant widely used in traditional African medicine for various indications, including epilepsy and erectile dysfunction [PMID:38270158, PMID:18638534].

Contexte

Securidaca longepedunculata (Family: Polygalaceae) is a plant found in the African continent, often harvested for its roots and root bark [PMID:24083577, PMID:38270158, PMID:41958734].

Usages traditionnels

Traditional uses include the management of epilepsy [PMID:38270158], treatment of erectile dysfunction in South Africa [PMID:18638534], and as a post-harvest protectant to control insect pests of stored grain and legumes in Ghana [PMID:11278061]. It is also used in traditional medicine for schistosomiasis [PMID:16621376].

Composés actifs

Identified compounds include methyl salicylate (the principal volatile component) [PMID:12112739, PMID:15856785], various xanthones (such as securidacaxanthone A and D, and muchimangins G-L) [PMID:16564647, PMID:40127435, PMID:24216090, PMID:24779644, PMID:25026713], triterpene saponins (including securidacaside A and B) [PMID:19769365, PMID:19863977], and phenolic compounds such as quercetin [PMID:20816646].

Mécanisme d'action

The root extract increases sodium currents and enhances contractile response in rat skeletal muscle cells [PMID:10465656]. Certain xanthones stimulate the relaxation of corpus cavernosal smooth muscle [PMID:18638534]. Other components may act by inhibiting acetylcholinesterase in specific pests [PMID:39701807] or by depleting antioxidant systems in the liver and kidney [PMID:20144964].

Preuves cliniques

Preuve DPain and Inflammation

Root-bark aqueous extract produced dose-dependent analgesic effects against thermally- and chemically-induced nociceptive pain and inhibited acute inflammation in mice/rats [PMID:18046514].

Preuve DDiabetes

Root-bark aqueous extract caused significant hypoglycaemia in rats [PMID:18046514]; methanol extract of leaves reversed experimental diabetes and associated pathology in Wistar albino rats [PMID:40778292].

Preuve DSeizures and Anxiety

Aqueous root extract produced a dose-dependent increase in the onset of strychnine- and picrotoxin-induced convulsions and showed anxiolytic activity in mice [PMID:20435127].

Preuve DErectile Dysfunction

Chloroform extracts of root bark induced relaxation of corpus cavernosal smooth muscle in rabbits [PMID:16309865]; isolated xanthones showed potent activity in relaxing the same muscle [PMID:18638534].

Preuve DParasitic Infections

Methanolic root extract demonstrated dose-dependent larvicidal effects against Heligmosomoides polygyrus and H. contortus in mice and in vitro [PMID:24083577].

Sécurité et effets indésirables

Aqueous root extract administered to male rats for 28 days induced redox imbalance by depleting antioxidant systems (SOD, catalase, GSH) and increasing lipid hydroperoxides in the liver and kidney [PMID:20144964]. High concentrations (6.5 mg/ml) of root bark extracts negatively affected human sperm parameters [PMID:16309865].

Synthèse des preuves

The current evidence is based entirely on preclinical studies (in vitro, animal models, and computational simulations), resulting in a low overall strength of clinical evidence (Level D).

Sources PubMed

1.PMID: 24083577 (2013) — Anthelmintic activity of Securidaca longepedunculata (Family: Polygalaceae) root extract in mice, in vitro and in vivo. · Asian Pacific journal of tropical medicine
2.PMID: 10465656 (1999) — The effects of Securidaca longepedunculata root extract on ionic currents and contraction of cultured rat skeletal muscle cells. · Journal of ethnopharmacology
3.PMID: 32908971 (2020) — Activities of Some Medicinal Plants on the Proliferation and Invasion of Brain Tumor Cell Lines. · Advances in pharmacological and pharmaceutical sciences
4.PMID: 38270158 (2024) — Inhibition of Seizure-Like Paroxysms and Toxicity Effects of Securidaca longepedunculata Extracts and Constituents in Zebrafish Danio rerio. · ACS chemical neuroscience
5.PMID: 39701807 (2025) — The inhibitory activities of two compounds from Securidaca longepedunculata Fresen on the acetylcholinesterase from wheat pest Schizaphis graminum Rondani: in silico analysis.

Securidaca longepedunculata

Sources et citations

Calculer une dose sûre de Securidaca longepedunculata